Your browser doesn't support javascript.
loading
DNTT activation, TdT-aided gene length mutation, and better prognosis in ATG-based regimen allo-HSCT in AML.
Zhou, Xiaosu; Nie, Daijing; Zhang, Yang; Liu, Zhixiu; Zhao, Yanli; Zhang, Jianping; Wang, Fang; Fang, Jiancheng; Cao, Panxiang; Chen, Xue; Ma, Xiaoli; Yuan, Lili; Chen, Jiaqi; Tan, Yincheng; Chen, Qihui; Liu, Ming; Liu, Mingyue; Liu, Yijun; Wu, Qisheng; Lu, Peihua; Liu, Hongxing.
Affiliation
  • Zhou X; Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China.
  • Nie D; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Zhang Y; Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China.
  • Liu Z; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Zhao Y; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Zhang J; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Wang F; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Fang J; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Cao P; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Chen X; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Ma X; Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China.
  • Yuan L; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Chen J; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Tan Y; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Chen Q; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Liu M; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Liu M; Department of Research and Development, Beijing Geneprofile Technologies Co., Ltd, Beijing, China.
  • Liu Y; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Wu Q; Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China.
  • Lu P; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Liu H; Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China.
Mol Carcinog ; 62(5): 665-675, 2023 05.
Article in En | MEDLINE | ID: mdl-36752333
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Carcinog Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2023 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Carcinog Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2023 Type: Article Affiliation country: China